Prenatal and Newborn Genetic Testing Market is estimated to increase at a growth rate of 13.5% CAGR over the forecast period from 2024 to 2030.
The global Prenatal and Newborn Genetic Testing Marketstudy analyzes and forecasts the market size across 6 regions and 24 countries for diverse segments including By Product (Consumables, Instruments), By Screening (Non-invasive Prenatal Testing, Chronic Villus Sampling, Amniocentesis, Maternal Serum Screening, Others), By Disease (Downs Syndrome, Phenylketonuria, Cystic Fibrosis, Sickle Cell Anemia), By End-user (Hospital, Maternity and Specialty Clinics, Diagnostic centers).
An introduction to Prenatal and Newborn Genetic Testing Market in 2024
Assessing genetic risk factors and prenatal health status, the Prenatal and Newborn Genetic Testing Market offers genetic screening and diagnostic tests for prenatal and neonatal care, allowing healthcare providers to identify chromosomal abnormalities, genetic disorders, and inherited conditions in fetuses and newborns. Prenatal genetic testing includes non-invasive prenatal screening (NIPS), amniocentesis, chorionic villus sampling (CVS), and carrier screening, while newborn genetic testing encompasses newborn screening panels, whole genome sequencing, and diagnostic testing for congenital disorders and metabolic conditions. This market encompasses laboratory testing services, diagnostic kits, and genetic counseling services provided by healthcare institutions, diagnostic laboratories, and genetic testing companies. The growth of this market is driven by advancements in genetic testing technologies, increasing awareness of genetic disorders, and efforts to improve early detection and intervention for genetic conditions affecting prenatal and newborn populations.
Prenatal and Newborn Genetic Testing market Trend: Advancements in Next-Generation Sequencing (NGS) Technology
A significant trend in the Prenatal and Newborn Genetic Testing market is the continuous advancements in next-generation sequencing (NGS) technology. NGS platforms have revolutionized genetic testing by enabling high-throughput sequencing of DNA samples, providing comprehensive insights into the fetal and neonatal genome. This trend towards NGS-based genetic testing allows for the detection of a wide range of genetic abnormalities and chromosomal disorders with greater accuracy, sensitivity, and efficiency than traditional methods. As NGS technologies become more accessible and cost-effective, there is an increasing adoption of prenatal and newborn genetic testing for early detection of genetic conditions, driving market growth and innovation in genetic testing platforms and assays.
Prenatal and Newborn Genetic Testing market Driver: Increasing Focus on Early Disease Detection and Personalized Medicine
A key driver in the Prenatal and Newborn Genetic Testing market is the increasing focus on early disease detection and personalized medicine approaches in pediatric healthcare. Genetic testing plays a crucial role in identifying genetic disorders and congenital anomalies in fetuses and newborns, enabling early intervention, personalized treatment planning, and family counseling. With advancements in genetic testing technologies and expanded newborn screening programs, healthcare providers can identify and manage genetic conditions more effectively, improving health outcomes for infants and children. The growing emphasis on early disease detection and personalized medicine drives demand for prenatal and newborn genetic testing services, fueling market growth and adoption of genetic testing technologies in pediatric healthcare settings.
Prenatal and Newborn Genetic Testing market Opportunity: Expansion into Non-invasive Prenatal Testing (NIPT) and Genetic Counseling Services
An enticing opportunity in the Prenatal and Newborn Genetic Testing market lies in the expansion into non-invasive prenatal testing (NIPT) and genetic counseling services. NIPT, which involves the analysis of cell-free fetal DNA in maternal blood, offers a safe and accurate screening method for common chromosomal abnormalities such as Down syndrome, trisomy 18, and trisomy 13 during pregnancy. Genetic counseling services play a vital role in providing information, support, and guidance to expecting parents regarding genetic testing options, test results interpretation, and family planning decisions. Companies that offer comprehensive NIPT and genetic counseling services can address the growing demand for prenatal genetic testing, enhance patient care, and differentiate themselves in the market by providing integrated solutions that support informed decision-making and optimal pregnancy outcomes, thus capitalizing on the expanding Market Opportunity in prenatal and newborn genetic testing.
Prenatal and Newborn Genetic Testing Market Market Segmentation
By Product
Consumables
Instruments
By Screening
Non-invasive Prenatal Testing
Chronic Villus Sampling
Amniocentesis
Maternal Serum Screening
Others
By Disease
Downs Syndrome
Phenylketonuria
Cystic Fibrosis
Sickle Cell Anemia
By End-User
Hospital
Maternity and Specialty Clinics
Diagnostic centers
Geographical Analysis
North America (United States, Canada, Mexico)
Europe (Germany, France, United Kingdom, Spain, Italy, Rest of Europe)
Asia Pacific (China, India, Japan, South Korea, Rest of Asia Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East and Africa (Saudi Arabia, UAE, Rest of Middle East, South Africa, Egypt, Rest of Africa)
Prenatal and Newborn Genetic Testing Market Companies
Abbott Laboratories
BGI Group
Bio-Rad Laboratories Inc
F. Hoffmann-La Roche AG
Laboratory Corp of America Holdings
Mettler Toledo
Natera Inc
PerkinElmer Inc
Quest Diagnostics Inc
Thermo Fisher Scientific Inc
Reasons to Buy the Prenatal and Newborn Genetic Testing Market Study
• Deepen your industry insights and navigate uncertainties for strategy formulation, CAPEX, and Operational decisions
• Gain access to detailed insights on the Prenatal and Newborn Genetic Testing Market, encompassing current market size, growth trends, and forecasts till 2030.
• Access detailed competitor analysis, enabling competitive advantage through a thorough understanding of market players, strategies, and potential differentiation opportunities
• Stay ahead of the curve with insights on technological advancements, innovations, and upcoming trends
• Identify lucrative investment avenues and expansion opportunities within the Prenatal and Newborn Genetic Testing Market industry, guided by robust, data-backed analysis.
• Understand regional and global markets through country-wise analysis, regional market potential, regulatory nuances, and dynamics
• Execute strategies with confidence and speed through information, analytics, and insights on the industry value chain
• Corporate leaders, strategists, financial experts, shareholders, asset managers, and governmental representatives can make long-term planning scenarios and build an integrated and timely understanding of market dynamics
• Benefit from tailored solutions and expert consultation based on report insights, providing personalized strategies aligned with specific business needs.
TABLE OF CONTENTS
1 Introduction to 2024 Prenatal and Newborn Genetic Testing Market
1.1 Market Overview
1.2 Quick Facts
1.3 Scope/Objective of the Study
1.4 Market Definition
1.5 Countries and Regions Analyzed
1.6 Units, Currency, and Conversions
1.7 Industry Value Chain
2 Research Methodology
2.1 Market Size Estimation
2.2 Sources and Research Methodology
2.3 Data Triangulation
2.4 Assumptions and Limitations
3 Executive Summary
3.1 Global Prenatal and Newborn Genetic Testing Market Size Outlook, $ Million, 2021 to 2030
3.2 Prenatal and Newborn Genetic Testing Market Outlook by Type, $ Million, 2021 to 2030
3.3 Prenatal and Newborn Genetic Testing Market Outlook by Product, $ Million, 2021 to 2030
3.4 Prenatal and Newborn Genetic Testing Market Outlook by Application, $ Million, 2021 to 2030
3.5 Prenatal and Newborn Genetic Testing Market Outlook by Key Countries, $ Million, 2021 to 2030
4 Market Dynamics
4.1 Key Driving Forces of Prenatal and Newborn Genetic Testing Industry
4.2 Key Market Trends in Prenatal and Newborn Genetic Testing Industry
4.3 Potential Opportunities in Prenatal and Newborn Genetic Testing Industry
4.4 Key Challenges in Prenatal and Newborn Genetic Testing Industry
5 Market Factor Analysis
5.1 Value Chain Analysis
5.2 Competitive Landscape
5.2.1 Global Prenatal and Newborn Genetic Testing Market Share by Company (%), 2023
5.2.2 Product Offerings by Company
5.3 Porter’s Five Forces Analysis
5.4 Pricing Analysis and Outlook
6 Growth Outlook Across Scenarios
6.1 Growth Analysis-Case Scenario Definitions
6.2 Low Growth Scenario Forecasts
6.3 Reference Growth Scenario Forecasts
6.4 High Growth Scenario Forecasts
7 Global Prenatal and Newborn Genetic Testing Market Outlook by Segments
7.1 Prenatal and Newborn Genetic Testing Market Outlook by Segments, $ Million, 2021- 2030
By Product
Consumables
Instruments
By Screening
Non-invasive Prenatal Testing
Chronic Villus Sampling
Amniocentesis
Maternal Serum Screening
Others
By Disease
Downs Syndrome
Phenylketonuria
Cystic Fibrosis
Sickle Cell Anemia
By End-User
Hospital
Maternity and Specialty Clinics
Diagnostic centers
8 North America Prenatal and Newborn Genetic Testing Market Analysis and Outlook To 2030
8.1 Introduction to North America Prenatal and Newborn Genetic Testing Markets in 2024
8.2 North America Prenatal and Newborn Genetic Testing Market Size Outlook by Country, 2021-2030
8.2.1 United States
8.2.2 Canada
8.2.3 Mexico
8.3 North America Prenatal and Newborn Genetic Testing Market size Outlook by Segments, 2021-2030
By Product
Consumables
Instruments
By Screening
Non-invasive Prenatal Testing
Chronic Villus Sampling
Amniocentesis
Maternal Serum Screening
Others
By Disease
Downs Syndrome
Phenylketonuria
Cystic Fibrosis
Sickle Cell Anemia
By End-User
Hospital
Maternity and Specialty Clinics
Diagnostic centers
9 Europe Prenatal and Newborn Genetic Testing Market Analysis and Outlook To 2030
9.1 Introduction to Europe Prenatal and Newborn Genetic Testing Markets in 2024
9.2 Europe Prenatal and Newborn Genetic Testing Market Size Outlook by Country, 2021-2030
9.2.1 Germany
9.2.2 France
9.2.3 Spain
9.2.4 United Kingdom
9.2.4 Italy
9.2.5 Russia
9.2.6 Norway
9.2.7 Rest of Europe
9.3 Europe Prenatal and Newborn Genetic Testing Market Size Outlook by Segments, 2021-2030
By Product
Consumables
Instruments
By Screening
Non-invasive Prenatal Testing
Chronic Villus Sampling
Amniocentesis
Maternal Serum Screening
Others
By Disease
Downs Syndrome
Phenylketonuria
Cystic Fibrosis
Sickle Cell Anemia
By End-User
Hospital
Maternity and Specialty Clinics
Diagnostic centers
10 Asia Pacific Prenatal and Newborn Genetic Testing Market Analysis and Outlook To 2030
10.1 Introduction to Asia Pacific Prenatal and Newborn Genetic Testing Markets in 2024
10.2 Asia Pacific Prenatal and Newborn Genetic Testing Market Size Outlook by Country, 2021-2030
10.2.1 China
10.2.2 India
10.2.3 Japan
10.2.4 South Korea
10.2.5 Indonesia
10.2.6 Malaysia
10.2.7 Australia
10.2.8 Rest of Asia Pacific
10.3 Asia Pacific Prenatal and Newborn Genetic Testing Market size Outlook by Segments, 2021-2030
By Product
Consumables
Instruments
By Screening
Non-invasive Prenatal Testing
Chronic Villus Sampling
Amniocentesis
Maternal Serum Screening
Others
By Disease
Downs Syndrome
Phenylketonuria
Cystic Fibrosis
Sickle Cell Anemia
By End-User
Hospital
Maternity and Specialty Clinics
Diagnostic centers
11 South America Prenatal and Newborn Genetic Testing Market Analysis and Outlook To 2030
11.1 Introduction to South America Prenatal and Newborn Genetic Testing Markets in 2024
11.2 South America Prenatal and Newborn Genetic Testing Market Size Outlook by Country, 2021-2030
11.2.1 Brazil
11.2.2 Argentina
11.2.3 Rest of South America
11.3 South America Prenatal and Newborn Genetic Testing Market size Outlook by Segments, 2021-2030
By Product
Consumables
Instruments
By Screening
Non-invasive Prenatal Testing
Chronic Villus Sampling
Amniocentesis
Maternal Serum Screening
Others
By Disease
Downs Syndrome
Phenylketonuria
Cystic Fibrosis
Sickle Cell Anemia
By End-User
Hospital
Maternity and Specialty Clinics
Diagnostic centers
12 Middle East and Africa Prenatal and Newborn Genetic Testing Market Analysis and Outlook To 2030
12.1 Introduction to Middle East and Africa Prenatal and Newborn Genetic Testing Markets in 2024
12.2 Middle East and Africa Prenatal and Newborn Genetic Testing Market Size Outlook by Country, 2021-2030
12.2.1 Saudi Arabia
12.2.2 UAE
12.2.3 Oman
12.2.4 Rest of Middle East
12.2.5 Egypt
12.2.6 Nigeria
12.2.7 South Africa
12.2.8 Rest of Africa
12.3 Middle East and Africa Prenatal and Newborn Genetic Testing Market size Outlook by Segments, 2021-2030
By Product
Consumables
Instruments
By Screening
Non-invasive Prenatal Testing
Chronic Villus Sampling
Amniocentesis
Maternal Serum Screening
Others
By Disease
Downs Syndrome
Phenylketonuria
Cystic Fibrosis
Sickle Cell Anemia
By End-User
Hospital
Maternity and Specialty Clinics
Diagnostic centers
13 Company Profiles
13.1 Company Snapshot
13.2 SWOT Profiles
13.3 Products and Services
13.4 Recent Developments
13.5 Financial Profile
List of Companies
Abbott Laboratories
BGI Group
Bio-Rad Laboratories Inc
F. Hoffmann-La Roche AG
Laboratory Corp of America Holdings
Mettler Toledo
Natera Inc
PerkinElmer Inc
Quest Diagnostics Inc
Thermo Fisher Scientific Inc
14 Appendix
14.1 Customization Offerings
14.2 Subscription Services
14.3 Related Reports
14.4 Publisher Expertise
By Product
Consumables
Instruments
By Screening
Non-invasive Prenatal Testing
Chronic Villus Sampling
Amniocentesis
Maternal Serum Screening
Others
By Disease
Downs Syndrome
Phenylketonuria
Cystic Fibrosis
Sickle Cell Anemia
By End-User
Hospital
Maternity and Specialty Clinics
Diagnostic centers
